Brokers' take
Manulife US Reit > Buy (maintained) DBS Equity Research, Aug 22 Aug 23 close: US$0.895 Target price: US$1.10
WE believe the Reit will continue to offer investors compelling value as its distribution per unit (DPU) remains on an uptrend given its ability to surprise on accretive acquisitions, and positive leasing spreads to drive earnings and net asset value (NAV) higher.
Moreover, Manulife US Reit's forward yield of 7 per cent stands at around 150 basis points higher than the S-Reit average but offers a superior 3-year DPU compound annual growth rate of around 4.5 per cent.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Carrier AirAsia discloses new listing plans under RM6.8 billion units merger
Intel slides after tepid forecast spurs fears about comeback
Microsoft beats estimates as AI drives revenue
Crypto firm sues SEC to fend off oversight of Ethereum
Snap beats first-quarter expectations, shares jump 25%
Google parent announces first-ever dividend; beats on sales, profit; shares soar